2026 NPPES data Hematology & Oncology Physician NPI 1730171968 MD
Verify on CMS →

GENE FINLEY, MD

Hematology & Oncology Physician in NATRONA HEIGHTS, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
771
Medicare Part D claims · 186 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.5698/100
▲ 2 pts above national avg 83.1 · [object Object]
Industry payments
$3.9K
186 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GENE FINLEY, MD reported a CMS MIPS final score of 85.5698/100 — above the 83.1 national average — and filed 771 Medicare Part D claims in 2023.

85.5698/100
MIPS score · +2 vs avg
771
Part D claims, 2023
67%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GENE FINLEY, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GENE FINLEY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GENE FINLEY, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/15/2005

NPI 1730171968

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

771 9% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

85.5698/100 2.4698000000000064% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Hematology & Oncology Physician share within Pennsylvania

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Pennsylvania

Medicare quality performance — MIPS

GENE FINLEY, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
85.5698/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 85.5698/100 vs national avg 83.1

0%100%National avg83%85.6%
MIPS final score (Hematology & Oncology Physician) — 85.5698/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GENE FINLEY, MD is a Hematology & Oncology Physician provider practicing in NATRONA HEIGHTS, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1730171968. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

GENE FINLEY, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1301 CARLISLE ST, NATRONA HEIGHTS, PA, 15065, with a listed phone of (724) 226-7105. NPI 1730171968 was issued on 08/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FINLEY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 771 prescription claims written by this provider, covering 186 Medicare beneficiaries and totaling roughly $3.6 million in drug spend, split 33% brand-name and 67% generic by claim count, with an opioid prescribing rate of 9.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.5698/100 for the 2023 performance year (Quality 86.6252, Cost 56.8769), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1301 CARLISLE ST
NATRONA HEIGHTS, PA 15065

Provider Details

NPI 1730171968
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 08/15/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.5698
Final Score
Avg: 83.1
86.6252
Quality
56.8769
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where GENE FINLEY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALLEGHENY CLINIC MEDICAL ONCOLOGY
KITTANNING, PA
PHOENIX REHABILITATION AND HEALTH SERVICES INC
CRANBERRY TOWNSHIP, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GENE FINLEY, MD. Source: openpaymentsdata.cms.gov.

Total received

$3.9K

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to GENE FINLEY, MD. To verify GENE FINLEY, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

GENE FINLEY, MD — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 771 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

771
Total Claims
$3.6M
Total Drug Cost
186
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
876
Total Day Supply
22,636
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$3.2M
Generic Drug Cost
$432K
Opioid Claims
76 (9.9% rate)
Antibiotic Claims
22

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
2.61
Gender Split
53% female / 47% male
Age Distribution
<65: 14, 65-74: 92, 75-84: 57, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Jakafi
Ruxolitinib Phosphate
60
Prochlorperazine Maleate
51
Anastrozole
44
Eliquis
Apixaban
39
Oxycodone Hcl
36
Hydroxyurea
32
Imbruvica
Ibrutinib
32
Revlimid
Lenalidomide
32
Dexamethasone
27
Imatinib Mesylate
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How GENE FINLEY, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

GENE FINLEY, MD's 771 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as FINLEY.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GENE FINLEY, MD's specialty?
GENE FINLEY, MD specializes in Hematology & Oncology Physician and practices in NATRONA HEIGHTS, Pennsylvania. Credentials: MD.
How much does GENE FINLEY, MD prescribe under Medicare Part D?
In 2023, GENE FINLEY, MD wrote 771 Medicare Part D claims totaling $3.6M in drug costs for 186 beneficiaries.
What is GENE FINLEY, MD's Medicare quality score?
GENE FINLEY, MD has a CMS MIPS Final Score of 85.5698/100 (Quality: 86.6252, Cost: 56.8769). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GENE FINLEY, MD located?
GENE FINLEY, MD is located at 1301 CARLISLE ST, NATRONA HEIGHTS, PA, 15065. Phone: (724) 226-7105.
What is GENE FINLEY, MD's NPI number?
GENE FINLEY, MD's National Provider Identifier (NPI) is 1730171968, issued on 08/15/2005.
Does GENE FINLEY, MD prescribe more brand-name or generic drugs?
GENE FINLEY, MD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $3.2M in brand drug costs.
Does GENE FINLEY, MD prescribe opioids?
Yes, GENE FINLEY, MD had 76 opioid claims in 2023 with an opioid prescribing rate of 9.9%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does GENE FINLEY, MD prescribe most often?
Based on 2023 Medicare Part D data, GENE FINLEY, MD's most frequently prescribed drugs include Jakafi, Prochlorperazine Maleate, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GENE FINLEY, MD accept Medicare?
GENE FINLEY, MD appears in CMS Medicare data with 771 Part D claims and 186 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GENE FINLEY, MD's credentials?
GENE FINLEY, MD's NPI is 1730171968 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology